Cargando…

Hashimoto Encephalopathy: A Rare Intricate Syndrome

Recently, several patients have been reported with various signs of encephalopathy and high thyroid antibody levels together with good responsiveness to glucocorticoid therapy. Despite the various clinical presentations, these cases have been termed “Hashimoto encephalopathy” (HE). Although all of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Payer, Juraj, Petrovic, Tomas, Lisy, Lubomir, Langer, Pavel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693614/
https://www.ncbi.nlm.nih.gov/pubmed/23843812
http://dx.doi.org/10.5812/ijem.4174
_version_ 1782274735404482560
author Payer, Juraj
Petrovic, Tomas
Lisy, Lubomir
Langer, Pavel
author_facet Payer, Juraj
Petrovic, Tomas
Lisy, Lubomir
Langer, Pavel
author_sort Payer, Juraj
collection PubMed
description Recently, several patients have been reported with various signs of encephalopathy and high thyroid antibody levels together with good responsiveness to glucocorticoid therapy. Despite the various clinical presentations, these cases have been termed “Hashimoto encephalopathy” (HE). Although all of the pathogenic components have not yet been clearly elucidated, it is believed that brain vasculitis and autoimmunity directed against common brain-thyroid antigens represent the most likely etiologic pathway. The most common clinical signs include unexplained or epilepsy-like seizures resistant to anti-convulsive treatment, confusion, headaches, hallucinations, stroke-like episodes, coma, impairment of cognitive function, behavioral and mood disturbance, focal neurological deficits, disturbance of consciousness, ataxia, and presenile dementia, together with the presence of high thyroid antibody levels, especially against thyroperoxidase (TPOab). In most cases, the thyroid function is normal or decreased; the thyroid function is rarely increased. The examination of the cerebrospinal fluid, EEG, MRI, SPECT, and neuropsychological examinations are primarily used as diagnostic tools. Most cases showed neural symptoms for months before the acute onset; in some cases, a dramatic acute onset was described. Once the diagnosis is made, corticosteroid treatment usually provides a dramatic recovery. The authors also present a short review of literary cases reported in last decade.
format Online
Article
Text
id pubmed-3693614
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Kowsar
record_format MEDLINE/PubMed
spelling pubmed-36936142013-07-10 Hashimoto Encephalopathy: A Rare Intricate Syndrome Payer, Juraj Petrovic, Tomas Lisy, Lubomir Langer, Pavel Int J Endocrinol Metab Case Report Recently, several patients have been reported with various signs of encephalopathy and high thyroid antibody levels together with good responsiveness to glucocorticoid therapy. Despite the various clinical presentations, these cases have been termed “Hashimoto encephalopathy” (HE). Although all of the pathogenic components have not yet been clearly elucidated, it is believed that brain vasculitis and autoimmunity directed against common brain-thyroid antigens represent the most likely etiologic pathway. The most common clinical signs include unexplained or epilepsy-like seizures resistant to anti-convulsive treatment, confusion, headaches, hallucinations, stroke-like episodes, coma, impairment of cognitive function, behavioral and mood disturbance, focal neurological deficits, disturbance of consciousness, ataxia, and presenile dementia, together with the presence of high thyroid antibody levels, especially against thyroperoxidase (TPOab). In most cases, the thyroid function is normal or decreased; the thyroid function is rarely increased. The examination of the cerebrospinal fluid, EEG, MRI, SPECT, and neuropsychological examinations are primarily used as diagnostic tools. Most cases showed neural symptoms for months before the acute onset; in some cases, a dramatic acute onset was described. Once the diagnosis is made, corticosteroid treatment usually provides a dramatic recovery. The authors also present a short review of literary cases reported in last decade. Kowsar 2012-04-20 2012 /pmc/articles/PMC3693614/ /pubmed/23843812 http://dx.doi.org/10.5812/ijem.4174 Text en Copyright © 2012, Research Institute For Endocrine Sciences and Iran Endocrine Society http://creativecommons.org/licenses/by/3/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Payer, Juraj
Petrovic, Tomas
Lisy, Lubomir
Langer, Pavel
Hashimoto Encephalopathy: A Rare Intricate Syndrome
title Hashimoto Encephalopathy: A Rare Intricate Syndrome
title_full Hashimoto Encephalopathy: A Rare Intricate Syndrome
title_fullStr Hashimoto Encephalopathy: A Rare Intricate Syndrome
title_full_unstemmed Hashimoto Encephalopathy: A Rare Intricate Syndrome
title_short Hashimoto Encephalopathy: A Rare Intricate Syndrome
title_sort hashimoto encephalopathy: a rare intricate syndrome
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693614/
https://www.ncbi.nlm.nih.gov/pubmed/23843812
http://dx.doi.org/10.5812/ijem.4174
work_keys_str_mv AT payerjuraj hashimotoencephalopathyarareintricatesyndrome
AT petrovictomas hashimotoencephalopathyarareintricatesyndrome
AT lisylubomir hashimotoencephalopathyarareintricatesyndrome
AT langerpavel hashimotoencephalopathyarareintricatesyndrome